Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes.
Nadeu F, Martin-Garcia D, Clot G, Díaz-Navarro A, Duran-Ferrer M, Navarro A, Vilarrasa-Blasi R, Kulis M, Royo R, Gutiérrez-Abril J, Valdés-Mas R, López C, Chapaprieta V, Puiggros M, Castellano G, Costa D, Aymerich M, Jares P, Espinet B, Muntañola A, Ribera-Cortada I, Siebert R, Colomer D, Torrents D, Gine E, López-Guillermo A, Küppers R, Martin-Subero JI, Puente XS, Beà S, Campo E.
Blood
136 :
2020
1419-1432
154
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms.
Nadeu F, Mas-de-Les-Valls R, Navarro A, Royo R, Martín S, Villamor N, Suárez-Cisneros H, Mares R, Lu J, Enjuanes A, Rivas-Delgado A, Aymerich M, Baumann T, Colomer D, Delgado J, Morin RD, Zenz T, Puente XS, Campbell PJ, Beà S, Maura F, Campo E.
Nat Commun
11 :
2020
3390
31
The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome.
Duran-Ferrer M, Clot G, Nadeu F, Beekman R, Baumann T, Nordlund J, Marincevic-Zuniga Y, Lönnerholm G, Rivas-Delgado A, Martín S, Ordoñez R, Castellano G, Kulis M, Queirós AC, Lee ST, Wiemels J, Royo R, Puiggrós M, Lu J, Giné E, Beà S, Jares P, Agirre X, Prosper F, López-Otín C, Puente XS, Oakes CC, Zenz T, Delgado J, López-Guillermo A, Campo E, Martín-Subero JI.
Nat Cancer
1 :
2020
1066-1081
70
PanCancer analysis of somatic mutations in repetitive regions reveals recurrent mutations in snRNA U2.
Bousquets-Muñoz P, Díaz-Navarro A, Nadeu F, Sánchez-Pitiot A, López-Tamargo S, Shuai S, Balbín M, Tubio JMC, Beà S, Martin-Subero JI, Gutiérrez-Fernández A, Stein LD, Campo E, Puente XS.
NPJ Genom Med
7 :
2022
19
15
Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma.
Sureda-Gómez M, Balsas P, Rodríguez ML, Nadeu F, De Bolòs A, Eguileor Á, Kulis M, Castellano G, López C, Giné E, Demajo S, Jares P, Martín-Subero JI, Beà S, Campo E, Amador V.
Leukemia
37 :
2023
408-421
9
SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma.
De Bolòs A, Sureda-Gómez M, Carreras-Caballé M, Rodríguez ML, Clot G, Beà S, Giné E, Campo E, Balsas P, Amador V.
Sci Rep
14 :
2024
7863
4
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.
Cirrincione AM, Poos AM, Ziccheddu B, Kaddoura M, Bärtsch MA, Maclachlan K, Chojnacka M, Diamond B, John L, Reichert P, Huhn S, Blaney P, Gagler D, Rippe K, Zhang Y, Dogan A, Lesokhin AM, Davies F, Goldschmidt H, Fenk R, Weisel KC, Mai EK, Korde N, Morgan GJ, Usmani S, Landgren O, Raab MS, Weinhold N, Maura F.
Blood
144 :
2024
771-783
9
The SOX11:SMARCA4 complex is a driver of oncogenic transcriptional programs in mantle cell lymphoma.
De Bolòs A, Carreras-Caballé M, Sureda-Gómez M, Rodríguez ML, Charalampopoulou S, Albero R, Maiques-Diaz A, Playa-Albinyana H, Clot G, López C, Colomer D, Martin-Subero JI, Campo E, Reverter D, Villanueva J, Amador V.
Blood Cancer J
15 :
2025
127
0
Fluctuating DNA methylation tracks cancer evolution at clinical scale.
Gabbutt C, Duran-Ferrer M, Grant HE, Mallo D, Nadeu F, Househam J, Villamor N, Müller M, Heath S, Raineri E, Krali O, Nordlund J, Zenz T, Gut IG, Campo E, Lopez-Guillermo A, Fitzgibbon J, Barnes CP, Shibata D, Martin-Subero JI, Graham TA.
Nature
645 :
2025
764-773
0
